Immunoconjugates with an intracellularly-cleavable linkage

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2508831

The invention relates to therapeutic conjugates with improved ability to target various cancer cells containing a targeting moiety and a therapeutic moiety. The targeting and therapeutic moieties are linked via an acid cleavable linkage that increases therapeutic efficacy of the immunoconjugate.

L'invention concerne des conjugués thérapeutiques capables de cibler diverses cellules cancéreuses, contenant un fragment de ciblage et un fragment thérapeutique. Ce fragment de ciblage et ce fragment thérapeutique sont reliés par une liaison clivable acide qui augmente le rendement thérapeutique de l'immunoconjugué.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunoconjugates with an intracellularly-cleavable linkage does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunoconjugates with an intracellularly-cleavable linkage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoconjugates with an intracellularly-cleavable linkage will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1712421

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.